Effect of anxiolytic, antidepressant, and antipsychotic drugs on cocaine-induced seizures and mortality

Epilepsy and Behavior

Volumn 5, Issue 6, 2004, Pages 852-856

  Macêdo, Danielle Silveira ^a   Santos, Rachel S ^a   Belchior, Luciana D ^a   Neto, Manoel Andrade ^a   Mendes Vasconcelos, Silvânia Maria ^a,b   Moreira Lima, Vera Targino ^a   França Fonteles, Marta Maria ^a   Barros Viana, Glauce Socorro ^a   de Sousa, Francisca Cléa Florenço ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b STATE UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Buspirone; Cocaine induced mortality; Cocaine induced seizures; Fluoxetine; Imipramine; Lithium; Naltrexone; Pimozide

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BUSPIRONE; COCAINE; FLUOXETINE; IMIPRAMINE; LITHIUM CARBONATE; NALTREXONE; NEUROLEPTIC AGENT; PIMOZIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; LATENT PERIOD; MALE; MENTAL DISEASE; MORTALITY; MOUSE; NONHUMAN; SEIZURE;

ANIMALS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; COCAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; MALE; MICE; REACTION TIME; SEIZURES;

EID: 10844226546     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yebeh.2004.07.012     Document Type: Article

References (36)

1. 2-like receptors in rat neostriatum Pharmacol Biochem Behav 62 1999 15-20
2. D.S. Macêdo F.C.F. Sousa S.M.M. Vasconcelos V.T.M. Lima G.S.B. Viana Different times of withdrawal from cocaine administration cause changes in muscarinic and dopaminergic receptors in rat premotor cortex Neurosci Lett 312 2001 129-132
3. D.S. Macêdo E.E. Correia S.M.M. Vasconcelos L.M.V. Aguiar G.S.B. Viana F.C.F. Sousa Cocaine treatment causes early and long-lasting changes in muscarinic and dopaminergic receptors Cell Mol Neurobiol 24 2004 129-136
4. R.B. Millman Evaluation and clinical management of cocaine abusers J Clin Psychiatry 49 1988 27-33
5. J.M. Witkin M. Gasior B. Heifets F.C. Tortella Anticonvulsant efficacy of N-methyl-d-aspartate antagonist against convulsions induced by cocaine J Pharmacol Exp Ther 289 1999 703-711
6. Substance Abuse and Mental Health Services Administration. Year-end preliminary estimates from 1996 drug abuse warning network. Publication No. (SMA) 98-3175, Rockville, MD: US. Department of Health Human Services; 1997
7. J.M. Witkin F.C. Tortella Modulators of N-methyl- d -aspartate protect against diazepam- or phenobarbital-resistant cocaine convulsions Life Sci 48 1991 51-56
8. M. Gasior R.B. Carter S.R. Goldberg J.M. Witkin Anticonvulsant and behavioral effects of neuroactive steroids alone and in conjunction with diazepam J Pharmacol Exp Ther 282 1997 543-553
9. W. Lason Neurochemical and pharmacological aspects of cocaine-induced seizures Pol J Pharmacol 53 2001 57-60
10. M.C. Ritz F.R. George Cocaine-induced convulsions: Pharmacological antagonism at serotonergic, muscarinic and sigma receptors Psychopharmacology 129 1997 299-310
11. D.S. Macedo S.M.M. Vasconcelos L.D. Belchior R.S. Santos G.S.B. Viana F.C.F. Sousa Alterations in monoamine levels after cocaine-induced status epilepticus and death in striatum and prefrontal cortex of mice Neurosci Lett 362 2004 185-188
12. US Department of Health and Human Services, Institute of Laboratory Animal Resources. Guide for the care and use of laboratory animals. Washington, DC: National Research Council; 1985
13. J.M. Ritchie N.M. Greene Local anesthetics In: A.G. Gilman L.S. Goodman T.W. Rall F. Murad, editors The pharmacological basis of therapeutics 7th ed. 1985 McMillan New York 302-321
14. A.T. Taylor P.J. Wagner D.C. Pritchard J.W. Tollison Fluoxetine in family practice patients J Fam Pract 39 1994 45-49
15. G.D. Tollefson M. Birkett L. Koran L. Genduso Continuation treatment of OCD: Double-blind and open-label experience with fluoxetine J Clin Psychiatry 55 1994 69-76
16. A. Wood Pharmacotherapy of bulimia nervosa: Experience with fluoxetine Int Clin Psychopharmacol 8 1993 295-299
17. D.A. Gorelick A. Paredes Effect of fluoxetine on alcohol consumption in male alcoholics Alcohol Clin Exp Res 16 1992 261-265
18. C.A. Naranjo C.X. Poulos K.E. Bremmer K.L. Lanctot Fluoxetine attenuates alcohol intake and desire to drink Int Clin Psychopharmacol 9 1994 163-172
19. K. Lee C. Kornetsky Acute and chronic fluoxetine treatment decreases the sensitivity of rats to rewarding brain stimulation Pharmacol Biochem Behav 60 1998 539-544
20. J.J. Platt Cocaine addiction: Theory, research and treatment 1997 Harvard Univ. Press Cambridge, MA p. 269
21. L.E. O'Dell R. Li F.R. George M.C. Ritz Molecular serotonergic mechanisms appear to mediate genetic sensitivity to cocaine-induced convulsions Brain Res 863 2000 213-224
22. M.J. Goldman L. Grinspoon S. Hunter-Jones Ritualistic use of fluoxetine by a former substance abuser [letter] Am J Psychiatry 147 1990 1377
23. J.A. Tinsley M.W. Olsen R.R. Laroche M.A. Palmen Fluoxetine abuse Mayo Clin Proc 69 1994 166-168
24. F.H. Gawin E.H. Ellinwood Cocaine and other stimulants: Actions, abuse and treatment N Engl J Med 318 1988 1173-1182
25. A.J. Giannini W. Billet D.A. Malone J.C. Giannini W.A. Price R.H. Loiselle Treatment of depression in chronic cocaine and phencyclidine abuse with desipramine J Clin Pharmacol 26 1986 211-214
26. A. Flemenbaum Does lithium block the effects of amphetamine? A report of three cases Am J Psychiatry 131 1974 820-821
27. A.J. Cronson A. Flemenbaum Antagonism of cocaine highs by lithium Am J Psychiatry 135 1978 856-857
28. R.A. Yokel R.A. Wise Increased lever pressing for amphetamine after pimozide in rats: Implications for a dopamine theory of reward Science 187 1975 547-549
29. W.L. Wooverton Effects of a D1 and a D2 dopamine antagonist on the self-administration of cocaine and piribedil by rhesus monkeys Pharmacol Biochem Behav 24 1986 531-535
30. I. Ushijima T. Kobayashi M. Suetsugi K. Watanabe M. Yamada K. Yamaguchi Cocaine: Evidence for NMDA-, β-carboline- and dopaminergic-mediated seizures in mice Brain Res 797 1998 347-350
31. E.J. Bilsky M.J. Montegut C.L. Delong L.D. Reid Opioidergic modulation of cocaine conditioned place preferences Life Sci 50 1992 85-90
32. T. Suzuki Y. Shiozaki Y. Masukawa M. Misawa H. Nagase The role of mu- and kappa-opioid receptors in cocaine-induced conditioned place preference Jpn J Pharmacol 58 1992 435-442
33. D. Braida E. Paladini E. Gori M. Sala Naltrexone, naltrindole and CTOP block cocaine-induced sensitization to seizures and death Peptides 18 1997 1189-1195
34. A.J. Gianini R.H. Loiselle B.H. Graham D.J. Folts Behavioral response to buspirone in cocaine and phencyclidine withdrawal J Subst Abuse Treat 10 1993 523-527
35. A.K. Louie R.A. Lannon E.A. Rutzick D. Browne T.B. Lewis R. Jones Clinical features of cocaine-induced panic Biol Psychiatry 40 1996 938-940
36. M.C. Ritz F. George Cocaine toxicity: Concurrent influence of dopaminergic, muscarinic and sigma receptors in mediating cocaine-induced lethality Psychopharmacology 129 1997 311-321